Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Long-Term Stability Testing – V 2.0

Posted on By

SOP for Long-Term Stability Testing – V 2.0

Procedure for Long-Term Stability Testing

Department Quality Control (QC)/Quality Assurance (QA)/Research & Development (R&D)
SOP No. SOP/Ointment/102
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define the procedure for conducting long-term stability testing of ointments to assess their physical, chemical, and microbiological stability over an extended period under recommended storage conditions.

2. Scope

This SOP applies to all personnel in the Quality Control (QC), Quality Assurance (QA), and Research & Development (R&D) departments responsible for executing, monitoring, and documenting long-term stability studies.

3. Responsibilities

  • QC Analyst: Conducts stability testing at predefined intervals.
  • QC Supervisor: Ensures compliance with the stability study protocol.
  • QA Officer: Reviews stability study data and ensures adherence to guidelines.
  • R&D Scientist: Analyzes data trends and recommends formulation adjustments if needed.
  • QA Manager: Approves stability study protocols and ensures regulatory compliance.
See also  Ointments: SOP for Primary and Secondary Packaging - V 2.0

4. Accountability

The QA and QC Managers are accountable for ensuring that long-term stability testing is conducted as per ICH Q1A(R2) guidelines.

5. Procedure

5.1 Preparation for Stability Testing

  • Ensure the stability study protocol is approved before initiating the study.
  • Select representative ointment batches for testing.
  • Label samples with batch number, manufacturing date, and storage conditions.
  • Store samples under recommended long-term conditions as per ICH guidelines (e.g., 25°C ± 2°C/60% RH ± 5% RH or 30°C ± 2°C/65% RH ± 5% RH, depending on regulatory requirements).

5.2 Stability Testing Parameters

  • Physical Properties: Assess changes in appearance, color, odor, and texture.
  • Chemical Stability: Analyze the active ingredient content using validated analytical methods.
  • Microbiological Testing: Perform microbial limit tests for contamination.
  • pH Measurement: Evaluate changes in pH levels over time.
  • Viscosity Analysis: Determine changes in consistency and spreadability.
See also  Ointments: SOP for Testing Residue Levels After Cleaning - V 2.0

5.3 Sampling Intervals

  • Collect samples for testing at predefined intervals: 0, 3, 6, 9, 12, 18, 24, and 36 months.
  • Perform all tests as per the approved stability study protocol.
  • Record observations and test results in the Stability Testing Log.

5.4 Handling Out-of-Specification (OOS) Results

  • Identify deviations from acceptance criteria.
  • Initiate an Out-of-Specification (OOS) investigation if required.
  • Implement corrective and preventive actions (CAPA) as necessary.

5.5 Documentation and Data Analysis

  • Record test results in the Stability Study Report.
  • Ensure data integrity and traceability.
  • QA must review and approve stability data before finalizing the report.

6. Abbreviations

  • GMP – Good Manufacturing Practices
  • QA – Quality Assurance
  • QC – Quality Control
  • ICH – International Council for Harmonisation
  • RH – Relative Humidity
  • OOS – Out-of-Specification

7. Documents

  • Stability Testing Log (Annexure-1)
  • Long-Term Stability Study Report (Annexure-2)
See also  Ointments: SOP for Dispensing Materials Using Automated Systems - V 2.0

8. References

  • ICH Q1A(R2) Stability Testing of New Drug Substances and Products
  • WHO GMP Guidelines for Pharmaceutical Stability Studies

9. SOP Version

Version 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Stability Testing Log

Date Batch Number Storage Condition Testing Interval Parameter Tested Result Reviewed By
01/02/2025 OINT-201 25°C/60% RH 6 Months Viscosity Compliant QA Officer
01/08/2025 OINT-201 25°C/60% RH 12 Months pH Stable QA Officer

Annexure-2: Long-Term Stability Study Report

Batch Number Study Start Date Study End Date Test Parameters Results Final Conclusion
OINT-201 01/02/2025 01/02/2028 pH, Viscosity, Microbial Limits Compliant Meets Stability Criteria
OINT-202 01/03/2025 01/03/2028 Appearance, Assay, Microbial Limits Compliant Meets Stability Criteria

12. Revision History:

Revision Date Revision No. Details of Revision Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP QA Head
01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

Post navigation

Previous Post: SOP for Sampling Plan Development for Different Raw Material Types – V 2.0
Next Post: Job Safety Analysis for Tablet Friability Tester

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version